NRX-101
-
NRx in Radnor Pens $345M+ Deal to Market Bipolar Drug
NRx Pharmaceuticals in Radnor has signed a licensing deal for its new drug candidate targeting bipolar depression, writes John George for Philadelphia Business Journal. The…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
